scar
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Voluntary Participation and Informed Consent:??Individuals who voluntarily agree to participate in this clinical study and provide written informed consent. ?2. Age and Gender Criteria:??Male or female subjects aged between 18 and 70 years old (inclusive). ?3. Surgical Wound Condition:??Patients with a linear sutured incision following thyroid surgery, exhibiting complete wound edge re-epithelialization.
Exclusion criteria
Exclusion criteria: 1.Females who are pregnant or lactating. 2.Subjects with other active local skin diseases, such as psoriasis or herpes simplex infection in the treatment area. 3.Subjects with pre-existing scars or skin disorders in the target treatment area that may interfere with efficacy assessment, or those with active and/or non-healed wounds. 4.Subjects with a history of hypertrophic scars or keloid formation (keloid tendency). 5.Subjects with a history of severe organ dysfunction or autoimmune diseases. 6.Subjects who have participated in any other clinical trial within 30 days prior to the screening period. 7.Subjects deemed by the investigator to be unsuitable for participation in this clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Modified Stony Brook Scar Evaluation Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual Analog Scale, VAS;Observer Scar Assessment Scale, OSAS;Patient Scar Assessment Scale, PSAS; | — |
Countries
China
Contacts
Peking University Shenzhen Hospital?